Signaturefd, LLC Corcept Therapeutics Inc Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Signaturefd, LLC holds 449 shares of CORT stock, worth $25,835. This represents 0.0% of its overall portfolio holdings.

Number of Shares

449

Previous 449 -0.0%

Holding current value

$25,835

Previous $14,000 42.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$21.1 - $27.46 $1,055 - $1,373	-50 Reduced 10.02%	449 $11,000
Q4 2023 Jan 31, 2024	SELL	$24.82 - $32.88 $1,315 - $1,742	-53 Reduced 9.6%	499 $16,000
Q3 2023 Nov 03, 2023	BUY	$21.97 - $33.8 $1,164 - $1,791	53 Added 10.62%	552 $15,000
Q2 2023 Aug 01, 2023	BUY	$21.44 - $25.15 $600 - $704	28 Added 5.94%	499 $11,000
Q1 2023 Apr 28, 2023	BUY	$19.2 - $24.47 $518 - $660	27 Added 6.08%	471 $10,000
Q2 2022 Aug 10, 2022	SELL	$17.33 - $25.3 $762 - $1,113	-44 Reduced 9.02%	444 $11,000
Q1 2022 May 02, 2022	BUY	$16.53 - $25.21 $4,413 - $6,731	267 Added 120.81%	488 $11,000
Q4 2021 Jan 25, 2022	BUY	$17.1 - $23.34 $752 - $1,026	44 Added 24.86%	221 $4,000
Q3 2021 Oct 28, 2021	SELL	$19.68 - $22.53 $255 - $292	-13 Reduced 6.84%	177 $3,000
Q2 2021 Jul 26, 2021	SELL	$19.97 - $24.43 $3,275 - $4,006	-164 Reduced 46.33%	190 $4,000
Q1 2021 Apr 30, 2021	BUY	$23.49 - $30.56 $5,567 - $7,242	237 Added 202.56%	354 $8,000
Q4 2020 Feb 11, 2021	BUY	$16.78 - $27.3 $671 - $1,092	40 Added 51.95%	117 $3,000
Q3 2020 Nov 03, 2020	BUY	$12.46 - $19.98 $959 - $1,538	77 New	77 $1,000

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account